Entering text into the input field will update the search result below

BioNTech finishes construction of first plasmid DNA manufacturing facility

Feb. 02, 2023 8:58 AM ETBioNTech SE (BNTX) StockBy: Jonathan Block, SA News Editor7 Comments

BioNTech And Pfizer To Begin Clinical Trial For Covid-19 Vaccine

Thomas Lohnes/Getty Images News

  • BioNTech (NASDAQ:BNTX) has completed the building of its first plasmid DNA manufacturing facility in Marburg, Germany.
  • Plasmid DNA are the building blocks for the manufacturing of mRNA-based vaccines and therapies, as well as cell therapies.
  • The new plant will be used in support of product candidates and commercial products in cancer and infectious diseases.
  • The facility actually covers two areas: clinical and commercial plasmid DNA. The clinical side is already running, while the commercial one should be operational by the end of the year.
  • See why Seeking Alpha contributor Terry Chrisomalis recently called BioNTech (BNTX) a strong buy.

Recommended For You

About BNTX Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
BNTX--
BioNTech SE